
Bahrain is cracking down on dissent as it struggles with the political and economic impacts of the war.
On Monday, several people were arrested on charges of spying for Iran, adding to more than 200 detained since the conflict began, according to the UK-based Bahrain Institute for Rights and Democracy. At least one man, Mohamed Almosawi, has died in custody. Rights groups said his corpse showed signs consistent with torture; the government dismissed the allegations as “misleading.”
The government is wary of protests, haunted by memories of the 2011 Arab Spring pro-democracy movement and historic enmity with Iran tracing back to the kingdom’s founding and Tehran sponsoring a failed coup in Manama in 1981.
Bahrain has intercepted more than 650 Iranian missiles and drones since the start of the war on Feb. 28. Unlike its Gulf peers, the kingdom can’t afford the economic consequences: This week, Capital Intelligence Ratings lowered the country’s credit rating one notch, and expects the budget deficit to spike this year because of the cost of repairing damaged infrastructure.
LATEST POSTS
- 1
A Manual for the Right SUV for Seniors - 2
Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it - 3
Indoor Drinking Fountains: Famous Home Advancements during the Pandemic - 4
Solar storms can trigger auroras on Earth. This star’s explosion could destroy a planet’s atmosphere - 5
Cruising Solo All over the Planet: An Excursion of Self-Disclosure
Fake new headlights rule steer Australian drivers astray
Investigate These Retreats Well known With Seniors
Exemplary Fragrances: A Manual for Notorious Scents
Israel launches new wave of attacks against Hezbollah in Beirut
Syrian army says recent drone attacks targeted its bases near Iraq, most shot down
Insurance warning signs in doctors’ offices might discourage patients from speaking openly about their health
The Best Games Crossroads in History
6 U.S. States for Climbing
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas













